Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has announced the application for quotation of 360,000 new ordinary fully paid securities on the ASX, marked with the issuer code FRE, effective from September 4, 2024. This move indicates an expansion of Firebrick’s financial activities and could potentially interest investors looking to diversify their portfolios with pharmaceutical sector stocks.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.